NONSPECIFIC SKIN HYPERREACTIVITY IN BEHCET'S DISEASETUEZUEN Y; ALTAC M; YAZICI H et al.1980; HAEMATOLOGICA; ITA; DA. 1980; VOL. 65; NO 3; PP. 395-398; ABS. ITA; BIBL. 9 REF.Article

Indications et résultats de la chirurgie des muscles oculomoteurs dans l'ophtalmopathie de Basedow-Graves = Indications and results of oculomoteur muscle surgery in Basedow-Graves ophtalmopathyOGUZ, V; PAZARLI, H; ÜSTÜNDAG, C et al.Ophtalmologie (Paris). 1996, Vol 10, Num 3, pp 304-306, issn 0989-3105Article

THE COMBINED USE OF HLA-B5 AND THE PATHERGY TEST AS DIAGNOSTIC MARKERS OF BEHCET'S DISEASE IN TURKEYYAZICI H; TUZUN Y; PAZARLI H et al.1980; J. RHEUMATOL.; CAN; DA. 1980; VOL. 7; NO 2; PP. 206-210; BIBL. 9 REF.Article

USEFULNESS OF HLA DETERMINATION AND PATHERGY TEST IN THE DIAGNOSIS OF UVEITIS IN TURKEYOZYAZGAN Y; PAZARLI H; YAZICI H et al.1981; BR. J. OPHTHALMOL.; ISSN 0007-1161; GBR; DA. 1981; VOL. 65; NO 11; PP. 798-799; BIBL. 6 REF.Article

BEHCET'S DISEASE: LACK OF CORRELATION OF CLINICAL MANIFESTATIONS WITH HLA ANTIGENSMUFTUOGLU AU; YAZICI H; YURDAKUL S et al.1981; TISSUE ANTIGENS; ISSN 0001-2815; DNK; DA. 1981; VOL. 17; NO 2; PP. 226-230; BIBL. 16 REF.Article

BEHCET'S DISEASE AS SEEN IN TURKEYYAZICI H; TUEZUEN Y; PAZARLI H et al.1980; HAEMATOLOGICA; ITA; DA. 1980; VOL. 65; NO 3; PP. 381-383; ABS. ITA; BIBL. 5 REF.Article

A DOUBLE BLIND STUDY OF COLCHICINE IN BEHCET'S DISEASEAKTULGA E; ALTAC M; MUEFTUEOGLU A et al.1980; HAEMATOLOGICA; ITA; DA. 1980; VOL. 65; NO 3; PP. 399-402; ABS. ITA; BIBL. 2 REF.Article

Valeur pronostique de l'antigène HLA B5 dans les uvéites antérieures isolées de la maladie de Behçet = Pronostic value of HLA B5 antigen in isolated anterior uveitis in Behcet's diseaseOGUZ, V; PAZARLI, H; OZYAZGAN, Y et al.Journal français d'ophtalmologie. 1989, Vol 12, Num 6-7, pp 431-432, issn 0181-5512Article

Les particularités cliniques et tomodensitométriques de l'ophtalmopathie de la maladie de Basedow-Graves en période de rémission et de la maladie de Basedow-Graves ophtalmique (ophtalmopathie basedowienne isolée) = Clinical and tomodensitometrical particularities of the ophthalmopathy during the remission of Graves' disease and Ophthalmic Graves' disease (isolated graves ophthalmopathy)OGUZ, V; PAZARLI, H; DÖVER, F et al.Ophtalmologie (Paris). 1996, Vol 10, Num 1, pp 59-62, issn 0989-3105Article

Localisation oculaire de la pigmentation dans la mélanocytose oculodermique = Ocular localisation of pigmentation in oculodermal melanocytosisOGUZ, V; PAZARLI, H; OCAKOGLU, Ö et al.Journal français d'ophtalmologie. 1995, Vol 18, Num 1, pp 40-43, issn 0181-5512Article

The prevalence of Sjögren's syndrome in Behçet's syndromeGÜNAYDIN, I; ÜSTÜNDAG, C; KANER, G et al.Journal of rheumatology. 1994, Vol 21, Num 9, pp 1662-1664, issn 0315-162XArticle

Les caractéristiques du début de l'atteinte oculaire dans la maladie de Behçet = The caracteristics of the onset of ocular involvement in Behçet's diseaseOGUZ, V; PAZARLI, H; ÖZYAZGAN, Y et al.Ophtalmologie (Paris). 1994, Vol 8, Num 4, pp 327-329, issn 0989-3105Article

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome : a single masked trialÖZYAZGAN, Y; YURDAKUL, S; YAZICI, H et al.British journal of ophthalmology. 1992, Vol 76, Num 4, pp 241-243, issn 0007-1161Article

Short term cyclosporin A treatment of Behçet's diseaseMUFTUOGLU, A. U; PAZARLI, H; YURDAKUL, S et al.British journal of ophthalmology. 1987, Vol 71, Num 5, pp 387-390, issn 0007-1161Article

A controlled trial of azathioprine in Behçet's syndromeYAZICI, H; PAZARLI, H; YAZICI, B et al.The New England journal of medicine. 1990, Vol 322, Num 5, pp 281-285, issn 0028-4793Article